Transcutaneous pacing is a way to control the heart’s rhythm from outside the body by sending electrical impulses through the chest wall via adhesive electrode pads. It’s a temporary, emergency intervention used when the heart beats dangerously slow and isn’t responding to medication. Unlike a permanent pacemaker, which is surgically implanted, transcutaneous pacing can be started in seconds with equipment already built into most defibrillator units found in emergency rooms and ambulances.
How It Works
Two large adhesive electrode pads are placed on the chest. A pulse generator connected to these pads delivers brief electrical impulses, each about 20 to 30 milliseconds long, that travel through the chest wall and stimulate the heart muscle to contract. The goal is to artificially set the heart’s pace when its own electrical system has failed or slowed to a dangerous degree.
The clinician adjusts two main settings: the pacing rate (how many beats per minute the device will target) and the output current (measured in milliamps), which is the strength of the electrical pulse. The output starts low and is gradually increased until the heart responds to each impulse, a moment known as “capture.” On a heart monitor, successful capture shows up as a wide QRS complex followed by a distinct T wave, confirming the heart muscle is depolarizing with each delivered pulse.
Where the Pads Go
Pad placement matters more than most people realize. The preferred setup is anterior-posterior: one pad on the front of the chest near the heart’s apex (roughly the lower left side of the chest), and the second pad on the back, between the spine and the left shoulder blade. This positions the heart directly between the two electrodes so the electrical current passes through as much cardiac tissue as possible.
An alternative is anterior-lateral placement, with both pads on the front and side of the chest. But a study comparing the two positions found that the anterior-posterior setup required an average of 93 milliamps to achieve capture, compared to 126 milliamps for the anterior-lateral position. That 33 milliamp difference is significant because lower current means less pain and less skeletal muscle stimulation for the patient. Major resuscitation guidelines now favor the anterior-posterior position for this reason.
When Transcutaneous Pacing Is Used
The American Heart Association classifies transcutaneous pacing as a first-line intervention for symptomatic bradycardia, meaning a heart rate slow enough to cause real problems. Those problems include confusion or altered mental status, severe chest pain, dangerously low blood pressure, signs of shock, or heart failure symptoms.
The typical sequence in an emergency starts with atropine, a medication that can speed the heart. If atropine doesn’t work, or if the situation is severe enough that waiting isn’t safe, transcutaneous pacing begins immediately. It’s also started without delay in higher-grade heart blocks, where the electrical signals between the upper and lower chambers of the heart are partially or completely interrupted. These blocks are less likely to respond to medication alone.
Transcutaneous pacing is always a bridge, not a destination. It keeps the patient alive and hemodynamically stable while the medical team arranges a more definitive solution, whether that’s a temporary internal pacing wire threaded through a vein or, eventually, a permanent implanted pacemaker.
What It Feels Like
This is the part most people want to know, and the honest answer is that it’s uncomfortable. Each electrical pulse strong enough to capture the heart also stimulates the skeletal muscles of the chest wall. Patients who are conscious typically feel a rhythmic thumping or jolting sensation with every paced beat. The chest muscles, and sometimes the muscles of the upper abdomen and arms, visibly twitch in time with the pacer.
The discomfort ranges from mildly annoying to genuinely painful depending on how much current is needed. Because of this, conscious patients are typically given sedation or pain medication to make the experience tolerable. In emergency situations where the patient is already unconscious or unresponsive, discomfort isn’t a concern, and pacing can proceed without delay.
Confirming It’s Actually Working
One of the trickier aspects of transcutaneous pacing is verifying that the electrical capture seen on the monitor is translating into actual heartbeats that move blood. This distinction between electrical capture and mechanical capture matters. The monitor may show what looks like a paced rhythm, but the heart may not actually be contracting effectively in response.
To confirm mechanical capture, clinicians check for a pulse that matches the paced rate. They may also use ultrasound to directly visualize the heart contracting. A case series studying prehospital transcutaneous pacing found that a high proportion of patients showed what appeared to be electrical capture on the monitor but were actually experiencing false capture, meaning the heart wasn’t truly responding. This finding underscores why checking a pulse or using ultrasound is essential rather than relying on the monitor alone.
Potential Complications
The most common side effect is pain from skeletal muscle contraction, which is essentially unavoidable at therapeutic current levels. Beyond discomfort, the rhythmic muscle twitching can make it harder for clinicians to assess the patient or perform other procedures.
Skin burns are a rarer but documented complication. In one reported case, an 86-year-old patient developed third-degree burns beneath the electrode pads from prolonged use. The risk increases with extended pacing duration, higher current settings, and poor pad contact with the skin. Electrical injury to the care team is also possible if proper precautions aren’t followed while the device is active.
Why It Sometimes Fails
Transcutaneous pacing doesn’t work every time. Success rates are inconsistent, and several factors make capture harder to achieve. Poor pad placement is the most common culprit. If the electrodes are positioned too close to the breastbone, or if they shift during patient movement, the current may travel along the skin surface rather than through the heart.
Body composition plays a role too. Patients with larger chest walls, significant obesity, or conditions like emphysema (which increases the air space between the chest wall and the heart) may need much higher current to achieve capture, sometimes exceeding the device’s maximum output. Fluid around the heart, certain metabolic imbalances, and the underlying cause of the slow rhythm can also reduce effectiveness. When transcutaneous pacing fails, the next step is usually placing a temporary pacing wire directly inside the heart through a vein.